D.E. Shaw & Co
MD icon

D.E. Shaw & Co’s Pediatrix Medical MD Stock Holding History

D.E. Shaw & Co’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-58,800
Closed -$2.69M – 4387
2013
Q2 		$2.69M Buy
+58,800
New +$2.63M 0.01% 1851

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

D.E. Shaw & Co's MD Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Pediatrix Medical (MD) stake by 5.6% in Q2 2026, selling an estimated $2.17M and leaving 1,613,100 shares worth $40.9M. The position accounts for 0.02% of the portfolio, ranked #868.

D.E. Shaw & Co first reported a position in MD in Q2 2013 and has held it in 46 quarters since. The position peaked at $85.1M in Q4 2019. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • D.E. Shaw & Co held 1,613,100 shares of Pediatrix Medical worth $40.9M as of Q2 2026.
  • D.E. Shaw & Co sold 95,333 Pediatrix Medical shares in Q2 2026, an estimated $2.17M.
  • Pediatrix Medical made up 0.02% of D.E. Shaw & Co's portfolio in Q2 2026, its #868 holding.
  • D.E. Shaw & Co first reported a position in Pediatrix Medical in Q2 2013 and has held it in 46 quarters since.
  • D.E. Shaw & Co's Pediatrix Medical position peaked at $85.1M in Q4 2019.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.